SLC16A1 and retinoblastoma: To further investigate the relationship between MCT1 expression and clinical parameters of RB development and progression, we conducted MCT1 immunostainings on a cohort of 47 RB samples, comprising 22 males (46.8%) and 25 females (53.2%).